… shape, and we think it transfers around the brain. We want to see if we can recreate this in non-human primates. Hypothesis: We are testing the hypothesis that we can get alpha-synuclein to transfer from site to site around the …

… Parkinson’s disease (PD) worsens over time, partly due to the spread of a harmful protein called α-synuclein … developed an antibody, NM-101, that blocks TLR2 and has shown promising results in lab and animal studies. However, … that can cross the BBB. We will use a technology called DNA barcoding to identify the most effective nanoparticles. …

… are the final and crucial step in delivering new drugs to pharmacy shelves. Yet 85% of trials face delays and 30% … trials in your area? Hear from members of the Parkinson's community who have raised their hand and participated in … volunteer "I was so impressed by the clinician and by how thoroughly my husband was examined. The doctors not only …

… the GB1A gene represent the most important genetic risk factor for Parkinson’s disease (PD) across the globe. However, different GBA1 variants are associated with varied … cognition and sleep dysfunction). This analysis will be complemented by examination of PD-related biofluid markers …

… the test of time, the beloved ‘80s sci-fi film “Back to the Future” marks its 35th anniversary from landing on … Parkinson’s Awareness Month by featuring a special commercial in honor of Michael J. Fox’s iconic role in the … business to go out of business. With your support we’re getting closer every day. Thank you for helping us get …

… If you or someone you know has Parkinson’s disease, you know how important it is to have access to affordable care services and medications … legislation reflects the needs of the patient and caregiver community.  Approximately 90 percent of people with …